Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 203

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer

Open access
Nava Rodrigues, Daniel, Rescigno, Pasquale, Liu, David, Yuan, Wei, Carreira, Suzanne, Lambros, Maryou B., Seed, George, Mateo, Joaquin, Riisnaes, Ruth, Mullane, Stephanie, Margolis, Claire, Miao, Diana, Miranda, Susana, Dolling, David, Clarke, Matthew, Bertan, Claudia, Crespo, Mateus, Boysen, Gunther, Ferreira, Ana, Sharp, Adam, Figueiredo, Ines, Keliher, Daniel, Aldubayan, Saud, Burke, Kelly P., Sumanasuriya, Semini, Fontes, Mariane Sousa, Bianchini, Diletta, Zafeiriou, Zafeiris, Teixeira Mendes, Larissa Sena, Mouw, Kent, Schweizer, Michael T., Pritchard, Colin C., Salipante, Stephen, Taplin, Mary-Ellen, Beltran, Himisha, Rubin, Mark A., Cieslik, Marcin, Robinson, Dan, Heath, Elizabeth, Schultz, Nikolaus, Armenia, Joshua, Abida, Wassim, Scher, Howard, Lord, Christopher, D’Andrea, Alan, Sawyers, Charles L., Chinnaiyan, Arul M., Alimonti, Andrea, Nelson, Peter S., Drake, Charles G., Van Allen, Eliezer M., de Bono, Johann S. · 2018 · Journal of Clinical Investigation

Abstract

BACKGROUND: Understanding the integrated immunogenomic landscape of advanced prostate cancer (APC) could impact stratified treatment selection. METHODS: Defective mismatch repair (dMMR) status was determined by either loss of mismatch repair protein expression on IHC or microsatellite instability (MSI) by PCR in 127 APC biopsies from 124 patients (Royal Marsden [RMH] cohort); MSI by targeted panel next-generation sequencing (MSINGS) was then evaluated in the same cohort and in 254 APC samples from the Stand Up To Cancer/Prostate Cancer Foundation (SU2C/PCF). Whole exome sequencing (WES) data from this latter cohort were analyzed for pathogenic MMR gene variants, mutational load, and mutational signatures. Transcriptomic data, available for 168 samples, was also performed. RESULTS: Overall, 8.1% of patients in the RMH cohort had some evidence of dMMR, which associated with decreased overall survival. Higher MSINGS scores associated with dMMR, and these APCs were enriched for higher T cell infiltration and PD-L1 protein expression. Exome MSINGS scores strongly correlated with targeted panel MSINGS scores (r = 0.73, P < 0.0001), and higher MSINGS scores associated with dMMR mutational signatures in APC exomes. dMMR mutational signatures also associated with MMR gene mutations and increased immune cell, immune checkpoint, and T cell-associated transcripts. APC with dMMR mutational signatures overexpressed a variety of immune transcripts, including CD200R1, BTLA, PD-L1, PD-L2, ADORA2A, PIK3CG, and TIGIT. CONCLUSION: These data could impact immune target selection, combination therapeutic strategy selection, and selection of predictive biomarkers for immunotherapy in APC. FUNDING: We acknowledge funding support from Movember, Prostate Cancer UK, The Prostate Cancer Foundation, SU2C, and Cancer Research UK.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci121924

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 203

Metadata

Authors
Nava Rodrigues, D., Rescigno, P., Liu, D., Yuan, W., Carreira, S., Lambros, M. B., Seed, G., Mateo, J., Riisnaes, R., Mullane, S., Margolis, C., Miao, D., Miranda, S., Dolling, D., Clarke, M., Bertan, C., Crespo, M., Boysen, G., Ferreira, A., Sharp, A., Figueiredo, I., Keliher, D., Aldubayan, S., Burke, K. P., Sumanasuriya, S., Fontes, M. S., Bianchini, D., Zafeiriou, Z., Teixeira Mendes, L. S., Mouw, K., Schweizer, M. T., Pritchard, C. C., Salipante, S., Taplin, M.-E., Beltran, H., Rubin, M. A., Cieslik, M., Robinson, D., Heath, E., Schultz, N., Armenia, J., Abida, W., Scher, H., Lord, C., D’Andrea, A., Sawyers, C. L., Chinnaiyan, A. M., Alimonti, A., Nelson, P. S., Drake, C. G., Van Allen, E. M., & de Bono, J. S.
Venue
Journal of Clinical Investigation
Published
2018-09-04
Volume
128
Issue
10
Pages
4441-4453
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W2892128235
Cited by
203
References
15
FWCI
9.52
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer. https://app.cochat.ai/papers/10.1172/jci121924
The paper
Nava Rodrigues, D., Rescigno, P., Liu, D., Yuan, W., Carreira, S., Lambros, M. B., Seed, G., Mateo, J., Riisnaes, R., Mullane, S., Margolis, C., Miao, D., Miranda, S., Dolling, D., Clarke, M., Bertan, C., Crespo, M., Boysen, G., Ferreira, A., . . . de Bono, J. S. (2018). Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer. Journal of Clinical Investigation. https://doi.org/10.1172/jci121924

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.